Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9

Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma

(2009) K. Kohga et al.   CANCER RESEARCH

How lipid flippases can modulate membrane structure

(2008) Philippe F. Devaux et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Tumor-Associated MICA Is Shed by ADAM Proteases

(2008) I. Waldhauer et al.   CANCER RESEARCH

Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma

(2008) Keisuke Kohga et al.   CANCER SCIENCE

Molecularly targeted therapy for hepatocellular carcinoma

(2008) Shinji Tanaka et al.   CANCER SCIENCE

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE